Revance Therapeutics Inc (RVNC)

[IanFromSI]

It certainly sounds as if unrealistic Daxxify expectations have been created. …. And at great harm to Revance’s share price potential.

In another post on this thread, it seems that Daxx performance peaks long prior to six months after the tx. … and slowly deteriorates over the next three or four months during which the Patient cannot have another tx. (Daxxify or anything else?)

This may be why Abbvie is seeing a greater need for a shorter duration Botox than something which competes with the unrealistic daxxify expectations.

I doubt that the market is flat out wrong. The price is down and staying down because there are more sellers than buyers as well. That’s just a natural result of all of the failures by RVNC and its management.